Cyclooxygenase-1 haplotype modulates platelet response to aspirin
- 9 September 2005
- journal article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 3 (10), 2340-2345
- https://doi.org/10.1111/j.1538-7836.2005.01555.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Aspirin and coronary artery diseaseThrombosis and Haemostasis, 2004
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJournal of the American College of Cardiology, 2003
- Genetic variation in cyclooxygenase 1: Effects on response to aspirinClinical Pharmacology & Therapeutics, 2003
- Cyclooxygenase 1(COX1) polymorphisms in African-American and caucasian populationsHuman Mutation, 2002
- Score Tests for Association between Traits and Haplotypes when Linkage Phase Is AmbiguousAmerican Journal of Human Genetics, 2002
- Genetic and Environmental Contributions to Platelet AggregationCirculation, 2001
- Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromesThe American Journal of Cardiology, 1999
- The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthaseNature Structural & Molecular Biology, 1995
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJCI Insight, 1982